Activation of c-Jun NH2-terminal kinase/stress-activated protein kinase (JNK/SAPK) is critical for hypoxia-induced apoptosis of human malignant melanoma

Cell Growth and Differentiation

Volumn 12, Issue 3, 2001, Pages 137-145

  Kunz, M ^a   Ibrahim, S ^a   Koczan, D ^a   Thiesen, H J ^a   Kohler H J ^a   Acker, T ^a   Plate, K H ^a   Ludwig, S ^a   Rapp, U R ^a   Brocker E B ^a   Van Muijen, G N P ^a   Flory, E ^a   Gross, G ^a  

^a UNIVERSITY OF ROSTOCK   (Germany)

Author keywords

[No Author keywords available]

Indexed keywords

2 (2 AMINO 3 METHOXYPHENYL)CHROMONE; 4 (4 FLUOROPHENYL) 2 (4 METHYLSULFINYLPHENYL) 5 (4 PYRIDYL)IMIDAZOLE; FAS LIGAND; MUTANT PROTEIN; STRESS ACTIVATED PROTEIN KINASE; SYNAPTOPHYSIN;

AMINO TERMINAL SEQUENCE; APOPTOSIS; ARTICLE; CONTROLLED STUDY; CORRELATION FUNCTION; ENZYME ACTIVATION; ENZYME INHIBITION; GENE OVEREXPRESSION; HUMAN; HUMAN CELL; HYPOXIA; IMMUNOHISTOCHEMISTRY; MELANOMA CELL; METASTASIS; PRIORITY JOURNAL; REGULATORY MECHANISM; SIGNAL TRANSDUCTION; TUMOR CELL;

ANOXIA; ANTIGENS, CD95; APOPTOSIS; GENE EXPRESSION REGULATION, NEOPLASTIC; HUMANS; IMMUNOHISTOCHEMISTRY; JNK MITOGEN-ACTIVATED PROTEIN KINASES; MAP KINASE KINASE 4; MELANOMA; MITOGEN-ACTIVATED PROTEIN KINASE KINASES; MITOGEN-ACTIVATED PROTEIN KINASES; NECROSIS; NEOPLASM INVASIVENESS; NEOVASCULARIZATION, PATHOLOGIC; PROTO-ONCOGENE PROTEINS C-JUN; RNA, MESSENGER; TRANSCRIPTION, GENETIC; TRANSFECTION; TUMOR CELLS, CULTURED;

EID: 0034920088     PISSN: 10449523     EISSN: None     Source Type: Journal    
DOI: None     Document Type: Article

References (46)

1. What is the evidence that tumors are angiogenesis dependent?
2. Vascular endothelial growth factor induced by hypoxia may mediate hypoxia-initiated angiogenesis
3. Upregulation of interleukin 8 by oxygen-deprived cells in glioblastoma suggests a role in leukocyte activation, chemotaxis, and angiogenesis
4. How tumors become angiogenic
5. 2 gradients in solid tumors in vivo: High resolution measurements reveal a lack of correlation
6. Hypoxia induces DNA overreplication and enhances metastatic potential of murine tumor cells
7. Hypoxia-mediated selection of cells with diminished apoptotic potential in solid tumors
8. The genomic response of tumor cells to hypoxia and reoxygenation. Differential activation of transcription factors AP-1 and NF-κB
9. Activation of vascular endothelial growth factor gene transcription by hypoxia-inducible factor-1
10. Hypoxia alters the subcellular distribution of the protein kinase C isoforms in neonatal rat ventricular myocytes
11. Hypoxia/reoxygenation stimulates Jun kinase activity through redox signaling in rat cardiac myocytes
12. Mitogen-activated protein kinase phosphatase-1 (MKP-1) expression is induced by low oxygen conditions found in solid tumor microenvironment
13. Mitogen-activated protein kinase pathways
14. The ins and outs of Raf kinases
15. MEKKs, GCKs, MLKs, PAKs, TAKs, and Tpls. Upstream regulators of the c-Jun amino-terminal kinases
16. The stress-activated protein kinase subfamily of c-Jun kinases
17. Protein kinase cascades activated by stress and inflammatory cytokines
18. Regulation and function of the JNK subgroup of MAP kinases
19. The search for physiological substrates of MAP and SAP kinases in mammalian cells
20. The stress inducer arsenite activates mitogen-activated protein kinases extracellular signal-regulated kinase 1 and 2 via a MAPK kinase 6/p38-dependent pathway
21. 3pk, a novel mitogen-activated protein (MAP) kinase activated protein kinase, is targeted by three MAP kinase pathways
22. Requirement for ceramide initiated SAPK/JNK signalling in stress-induced apoptosis
23. The c-Jun N-terminal kinase cascade plays a role in stress-induced apoptosis in Jurkat cells by up-regulating Fas ligand expression
24. Dopamine induces apoptosis through an oxidation-involved SAPK/JNK activation pathway
25. Withdrawal of survival factors in neuronal cells leading to Fas ligand induction and cell death
26. Stress signals for apoptosis: Ceramide and c-Jun kinase
27. Multiple pathways originate at the FAS/Apo-1 (CD95) receptor: Sequential involvement of phosphatidylcholine-specific phospholipase C and acidic sphingomyelinase in the propagation of the apoptotic signal
28. Activation of CD95 (APO-1/Fas) signaling by ceramide mediates cancer therapyinduced apoptosis
29. 2- terminal kinase mediated activation of interleukin-1β converting enzyme/CED-3-like protease during anticancer drug-induced apoptosis
30. Stress-signaling kinase SEK1 protects thymocytes from mediated by CD95 and CD3
31. Early lethalty, functional NF-κB activation, and increased sensitivity to TNF-induced cell death in TRAF2-deficient mice
32. Dissection of TNF receptor 1 effector functions: JNK activation is not linked to apoptosis while NF-κB activation prevents cell death
33. Lack of a role for Jun kinase and AP-1 in Fas-induced apoptosis
34. Role of the human heat shock protein hsp 70 in protection against stress-induced apoptosis
35. Activation of SAPK/JNK by TNF receptor 1 through a noncytotoxic TRAF2-dependent pathway
36. Regulation of JNK signaling by GSTp
37. Role of SAPK/ERK kinase-1 in the stress-activated pathway regulating transcription factor c-Jun
38. Selective interaction of JNK protein kinase isoforms with transcription factors
39. A matter of life and cell death
40. Different MAPK signaling pathways cooperate to regulate TNF-α gene expression in T lymphocytes
41. Antigen expression of metastasizing and non-metastasizing human melanoma cells xenografted into nude mice
42. Hypoxia-induced up-regulation of angiogenin in human malignant melanoma
43. Anoxia-induced upregulation of interleukin-8 in human malignant melanoma. A potential mechanism for high tumor aggressiveness
44. Up-regulation of hypoxia-inducible factors HIF-1α and HIF-2α under normoxic conditions in renal carcinoma cells by von Hippel-Lindau tumor suppressor gene loss of function
45. Annexin V for flow cytometric detection of phosphatidylserine expression on B cells undergoing apoptosis
46. FasL:Fas ratio: A prognostic factor in breast carcinomas